InvestSMART

ImpediMed Limited (ASX: IPD) - Announcements

- Current share price for IPD : $0.005

ASX company news and announcements for ImpediMed Limited (IPD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ImpediMed Limited (IPD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ImpediMed Limited (IPD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ImpediMed Limited (IPD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Application for quotation of securities - IPD 23 Dec 2025 4:24PM $0.035 $0.005 fallen by 85.71%
$18 Positive Momentum in US Reimbursement Coverage Continues 4 Dec 2025 8:18AM $0.036 $0.005 fallen by 85.92%
$18 Receipt of R&D tax incentive refund 24 Nov 2025 5:04PM $0.035 $0.005 fallen by 85.71%
$18 AGM - Results of Meeting 18 Nov 2025 1:45PM $0.036 $0.005 fallen by 86.11%
$18 AGM - CEO's Presentation 18 Nov 2025 10:24AM $0.040 $0.005 fallen by 87.50%
$18 AGM - Chair's Address 18 Nov 2025 10:21AM $0.040 $0.005 fallen by 87.50%
$18 Change of Director's Interest Notice - Mr Andrew Grant 6 Nov 2025 8:24PM $0.036 $0.005 fallen by 86.11%
$18 Change of Director's Interest Notice - Ms Emmanuel-Donnelly 6 Nov 2025 8:24PM $0.036 $0.005 fallen by 86.11%
$18 Change of Director's Interest Notice - Ms Janelle Delaney 6 Nov 2025 8:23PM $0.036 $0.005 fallen by 86.11%
$18 Change of Director's Interest Notice - Ms Fiona Bones 6 Nov 2025 8:21PM $0.036 $0.005 fallen by 86.11%
$18 Application for quotation of securities - IPD 6 Nov 2025 8:20AM $0.037 $0.005 fallen by 86.49%
$18 Application for quotation of securities - IPD 6 Nov 2025 8:20AM $0.037 $0.005 fallen by 86.49%
$18 Investor Presentation 30 Oct 2025 8:19AM $0.046 $0.005 fallen by 89.13%
$18 Quarterly Activities Report and Appendix 4C - Sep-2025 Qtr 30 Oct 2025 8:19AM $0.046 $0.005 fallen by 89.13%
$18 Q1 FY26 results webinar & launch of Impedimed Investor Hub 24 Oct 2025 3:44PM $0.044 $0.005 fallen by 88.64%
$18 Notification regarding FY26 Non-executive Director fees 23 Oct 2025 6:43PM $0.042 $0.005 fallen by 88.10%
$18 Investor Presentation - Canaccord Drug and Device Conference 22 Oct 2025 8:22AM $0.040 $0.005 fallen by 87.50%
$18 Online Meeting Guide 16 Oct 2025 9:49AM $0.042 $0.005 fallen by 88.10%
$18 Notice of Annual General Meeting & Voting Form 16 Oct 2025 9:48AM $0.042 $0.005 fallen by 88.10%
$18 Notification of cessation of securities - IPD 13 Oct 2025 11:52AM $0.045 $0.005 fallen by 88.89%
$18 Notification regarding unquoted securities - IPD 13 Oct 2025 11:49AM $0.045 $0.005 fallen by 88.89%
$18 Major US health insurer publishes positive coverage 2 Oct 2025 8:39AM $0.037 $0.005 fallen by 86.49%
$18 Date of Annual General Meeting 19 Sep 2025 8:29AM $0.035 $0.005 fallen by 85.71%
$18 Application for quotation of securities - IPD 4 Sep 2025 8:22AM $0.039 $0.005 fallen by 87.18%
$18 Appendix 4G and Corporate Governance Statement 28 Aug 2025 8:20AM $0.043 $0.005 fallen by 88.37%

76 - 100 of 1208 results

Page 4 of 49

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.